Health AI Central
Share:
Peer-Reviewed Publication
Am J Manag Care2025;31(1):e4-e10.January 1, 2025Journal Article

Effects of individualized nurse-led care plans on olaparib treatment duration.

Denise Tran, Haesuk Park, Jordon Rabey, Seth Killion, S Bobby Arelli, Elaine Murphy, Yoona Kim1
1Arine, 595 Market St #2550, San Francisco, CA 94105. Email: ykim@arine.io.
PubMed DOI

Abstract

OBJECTIVE: To assess the effects of a nurse-led personalized care plan on the duration of olaparib therapy among patients with cancer. STUDY DESIGN: Cohort study conducted from January 2020 to June 2022. METHODS: Data from an independent specialty pharmacy were used to identify patients 18 years and older with at least 1 olaparib (Lynparza) prescription who were at high risk for olaparib nonadhe…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.